Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Clin Trials. 2016 Feb 24;13(3):319–330. doi: 10.1177/1740774516631735

Table 2.

a. Recruitment Source: Mass Mailings

Randomization Status* Randomization
Yield (%)
    Category Screened
(N=4829)
Not Randomized
(N=1827)
Randomized
(N=3002)
Sex
    Female 1701 (35.3%) 854 (46.8%) 847 (28.2%) 49.8
    Male 3124 (64.7%) 969 (53.2%) 2155 (71.8%) 69
Race/Ethnicity .
    African
American
1491 (30.9%) 654 (35.8%) 837 (27.9%) 56.1
    Hispanic 169
(3.5%)
61 (3.3%) 108 (3.6%) 63.9
    Other 120
(2.5%)
60 (3.3%) 60 (2.0%) 50
    White 3048 (63.1%) 1051 (57.6%) 1997 (66.5%) 65.5
CKD Status .
    eGFR ≥ 60 2889 (73.7%) 710 (77.3%) 2179 (72.6%) 75.4
    eGFR < 60
(CKD subgroup)
1031 (26.3%) 208 (22.7%) 823 (27.4%) 79.8
Age .
    < 75 Years Old 3098 (64.2%) 1290 (70.8%) 1808 (60.2%) 58.4
    ≥ 75 Years Old 1726 (35.8%) 532 (29.2%) 1194 (39.8%) 69.2
CVD History .
    None 3465 (81.5%) 1068 (85.3%) 2397 (79.8%) 69.2
    Clinical or
Subclinical CVD
789 (18.5%) 184 (14.7%) 605 (20.2%) 76.7
Framingham Risk
Score - % mean
16.2 ± 3.7 13.4 ± 4.0 17.8 ± 2.4
b. Recruitment Source: Media: television, radio, newspaper, internet, toll-free number
Randomization Status* Randomization
Yield (%)
    Category Screened
(N=1244)
Not
Randomized
(N=544)
Randomized
(N=700)
Sex
    Female 635 (51.1%) 319 (58.9%) 316 (45.1%) 49.8
    Male 607 (48.9%) 223 (41.1%) 384 (54.9%) 63.3
Race/Ethnicity .
    African American 460 (37.0%) 253 (46.5%) 207 (29.6%) 45
    Hispanic 146 (11.7%) 23 (4.2%) 123 (17.6%) 84.2
    Other 25 (2.0%) 11 (2.0%) 14 (2.0%) 56
    White 613 (49.3%) 257 (47.2%) 356 (50.9%) 58.1
CKD Status .
    eGFR ≥ 60 829 (84.8%) 252 (90.6%) 577 (82.4%) 69.6
    eGFR < 60 (CKD
subgroup)
149 (15.2%) 26 (9.4%) 123 (17.6%) 82.6
Age .
    < 75 Years Old 1041 (83.7%) 457 (84.0%) 584 (83.4%) 56.1
    ≥ 75 Years Old 203 (16.3%) 87 (16.0%) 116 (16.6%) 57.1
CVD History .
    None 962 (91.1%) 337 (94.7%) 625 (89.3%) 65
    Clinical or Subclinical
CVD
94 (8.9%) 19 (5.3%) 75 (10.7%) 79.8
Framingham Risk Score -
% mean
15.3 ± 3.5 12.9 ± 3.7 16.9 ± 2.3
c. Recruitment Source: Brochure or Poster
Randomization Status* Randomization
Yield (%)
    Category Screened
(N=2195)
Not Randomized
(N=879)
Randomized
(N=1316)
Sex
    Female 923 (42.1%) 452 (51.5%) 471 (35.8%) 51
    Male 1271 (57.9%) 426 (48.5%) 845 (64.2%) 66.5
Race/Ethnicity .
    African
American
728 (33.2%) 325 (37.1%) 403 (30.6%) 55.4
    Hispanic 131 (6.0%) 26 (3.0%) 105 (8.0%) 80.2
    Other 63 (2.9%) 31 (3.5%) 32 (2.4%) 50.8
    White 1271 (58.0%) 495 (56.4%) 776 (59.0%) 61.1
CKD Status .
    eGFR ≥ 60 1415 (79.5%) 374 (80.8%) 1041 (79.1%) 73.6
    eGFR < 60
(CKD subgroup)
364 (20.5%) 89 (19.2%) 275 (20.9%) 75.5
Age .
    < 75 Years Old 1584 (72.3%) 663 (75.7%) 921 (70.0%) 58.1
    ≥ 75 Years Old 608 (27.7%) 213 (24.3%) 395 (30.0%) 65
CVD History .
    None 1672 (85.7%) 562 (88.6%) 1110 (84.3%) 66.4
    Clinical or
Subclinical CVD
278 (14.3%) 72 (11.4%) 206 (15.7%) 74.1
Framingham Risk
Score - % mean
15.7 ± 3.7 13.1 ± 3.9 17.3 ± 2.4
d. Recruitment Source: Referral from SPRINT Staff, Healthcare Provider, Friends
Randomization Status* Randomization
Yield (%)
    Category Screened
(N=6555)
Not
Randomized
(N=2069)
Randomized
(N=4486)
Sex
    Female 2820 (43.0%) 1076 (52.0%) 1744
(38.9%)
61.8
    Male 3734 (57.0%) 992 (48.0%) 2742
(61.1%)
73.4
Race/Ethnicity .
    African American 2302 (35.3%) 851 (41.7%) 1451
(32.3%)
63
    Hispanic 807 (12.4%) 131 (6.4%) 676 (15.1%) 83.8
    Other 122 (1.9%) 58 (2.8%) 64 (1.4%) 52.5
    White 3298 (50.5%) 1003 (49.1%) 2295
(51.2%)
69.6
CKD Status .
    eGFR ≥ 60 3968 (68.2%) 952 (71.4%) 3016
(67.2%)
76
    eGFR < 60 (CKD
subgroup)
1851 (31.8%) 381 (28.6%) 1470
(32.8%)
79.4
Age .
    < 75 Years Old 5145 (78.6%) 1695 (82.2%) 3450
(76.9%)
67.1
    ≥ 75 Years Old 1402 (21.4%) 366 (17.8%) 1036
(23.1%)
73.9
CVD History .
    None 4699 (78.0%) 1248 (81.0%) 3451
(76.9%)
73.4
    Clinical or Subclinical
CVD
1327 (22.0%) 292 (19.0%) 1035
(23.1%)
78
Framingham Risk Score -
% mean
16.2 ± 3.5 13.7 ± 4.1 17.3 ± 2.6
*

p-value for difference in randomization status between groups ≤ 0.001 for all categories except CKD (p-value=0.0004)

*

p-value for difference in randomization status between groups ≤ 0.001 for all categories except age (p=0.78)

*

p-value for difference in randomization status between groups ≤ 0.001 for all categories except age (p=0.004) and CVD (p=0.011)

*

p-value for difference in randomization status between groups ≤ 0.001 for all categories except CKD (p=0.004)